Cargando…
Incretins in patients with rheumatoid arthritis
BACKGROUND: The precise mechanism linking systemic inflammation with insulin resistance (IR) in rheumatoid arthritis (RA) remains elusive. In the present study, we determined whether the incretin-insulin axis and incretin effect are disrupted in patients with RA and if they are related to the IR fou...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645916/ https://www.ncbi.nlm.nih.gov/pubmed/29041949 http://dx.doi.org/10.1186/s13075-017-1431-9 |
_version_ | 1783271981196509184 |
---|---|
author | Tejera-Segura, Beatriz López-Mejías, Raquel Domínguez-Luis, María Jesús de Vera-González, Antonia M. González-Delgado, Alejandra Ubilla, Begoña Olmos, José M. Hernández, José L. González-Gay, Miguel A. Ferraz-Amaro, Iván |
author_facet | Tejera-Segura, Beatriz López-Mejías, Raquel Domínguez-Luis, María Jesús de Vera-González, Antonia M. González-Delgado, Alejandra Ubilla, Begoña Olmos, José M. Hernández, José L. González-Gay, Miguel A. Ferraz-Amaro, Iván |
author_sort | Tejera-Segura, Beatriz |
collection | PubMed |
description | BACKGROUND: The precise mechanism linking systemic inflammation with insulin resistance (IR) in rheumatoid arthritis (RA) remains elusive. In the present study, we determined whether the incretin-insulin axis and incretin effect are disrupted in patients with RA and if they are related to the IR found in these patients. METHODS: We conducted a cross-sectional study that encompassed 361 subjects without diabetes, 151 patients with RA, and 210 sex-matched control subjects. Insulin, C-peptide, glucagon-like peptide-1 (GLP-1), gastric inhibitory polypeptide (GIP), dipeptidyl peptidase 4 (DPP-4) soluble form, and IR indexes by homeostatic model assessment (HOMA2) were assessed. A multivariable analysis adjusted for IR-related factors was performed. Additionally, ten patients and ten control subjects underwent a 566-kcal meal test so that we could further study the postprandial differences of these molecules between patients and control subjects. RESULTS: Insulin, C-peptide, and HOMA2-IR indexes were higher in patients than in control subjects. This was also the case for GLP-1 (0.49 ± 1.28 vs. 0.71 ± 0.22 ng/ml, p = 0.000) and GIP (0.37 ± 0.40 vs. 1.78 ± 0.51 ng/ml, p = 0.000). These differences remained significant after multivariable adjustment including glucocorticoid intake. Disease Activity Score in 28 joints with erythrocyte sedimentation rate (β coefficient 46, 95% CI 6–87, p = 0.026) and Clinical Disease Activity Index (β coefficient 7.74, 95% CI 1.29–14.20, p = 0.019) were associated with DPP-4 serum levels. GLP-1 positively correlated with β-cell function (HOMA2 of β-cell production calculated with C-peptide) in patients but not in control subjects (interaction p = 0.003). The meal test in patients with RA revealed a higher total and late response AUC for glucose response, a later maximal response of C-peptide, and a flatter curve in GIP response. CONCLUSIONS: The incretin-insulin axis, both during fasting and postprandial, is impaired in patients with RA. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1431-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5645916 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-56459162017-10-26 Incretins in patients with rheumatoid arthritis Tejera-Segura, Beatriz López-Mejías, Raquel Domínguez-Luis, María Jesús de Vera-González, Antonia M. González-Delgado, Alejandra Ubilla, Begoña Olmos, José M. Hernández, José L. González-Gay, Miguel A. Ferraz-Amaro, Iván Arthritis Res Ther Research Article BACKGROUND: The precise mechanism linking systemic inflammation with insulin resistance (IR) in rheumatoid arthritis (RA) remains elusive. In the present study, we determined whether the incretin-insulin axis and incretin effect are disrupted in patients with RA and if they are related to the IR found in these patients. METHODS: We conducted a cross-sectional study that encompassed 361 subjects without diabetes, 151 patients with RA, and 210 sex-matched control subjects. Insulin, C-peptide, glucagon-like peptide-1 (GLP-1), gastric inhibitory polypeptide (GIP), dipeptidyl peptidase 4 (DPP-4) soluble form, and IR indexes by homeostatic model assessment (HOMA2) were assessed. A multivariable analysis adjusted for IR-related factors was performed. Additionally, ten patients and ten control subjects underwent a 566-kcal meal test so that we could further study the postprandial differences of these molecules between patients and control subjects. RESULTS: Insulin, C-peptide, and HOMA2-IR indexes were higher in patients than in control subjects. This was also the case for GLP-1 (0.49 ± 1.28 vs. 0.71 ± 0.22 ng/ml, p = 0.000) and GIP (0.37 ± 0.40 vs. 1.78 ± 0.51 ng/ml, p = 0.000). These differences remained significant after multivariable adjustment including glucocorticoid intake. Disease Activity Score in 28 joints with erythrocyte sedimentation rate (β coefficient 46, 95% CI 6–87, p = 0.026) and Clinical Disease Activity Index (β coefficient 7.74, 95% CI 1.29–14.20, p = 0.019) were associated with DPP-4 serum levels. GLP-1 positively correlated with β-cell function (HOMA2 of β-cell production calculated with C-peptide) in patients but not in control subjects (interaction p = 0.003). The meal test in patients with RA revealed a higher total and late response AUC for glucose response, a later maximal response of C-peptide, and a flatter curve in GIP response. CONCLUSIONS: The incretin-insulin axis, both during fasting and postprandial, is impaired in patients with RA. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13075-017-1431-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-10-17 2017 /pmc/articles/PMC5645916/ /pubmed/29041949 http://dx.doi.org/10.1186/s13075-017-1431-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Tejera-Segura, Beatriz López-Mejías, Raquel Domínguez-Luis, María Jesús de Vera-González, Antonia M. González-Delgado, Alejandra Ubilla, Begoña Olmos, José M. Hernández, José L. González-Gay, Miguel A. Ferraz-Amaro, Iván Incretins in patients with rheumatoid arthritis |
title | Incretins in patients with rheumatoid arthritis |
title_full | Incretins in patients with rheumatoid arthritis |
title_fullStr | Incretins in patients with rheumatoid arthritis |
title_full_unstemmed | Incretins in patients with rheumatoid arthritis |
title_short | Incretins in patients with rheumatoid arthritis |
title_sort | incretins in patients with rheumatoid arthritis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5645916/ https://www.ncbi.nlm.nih.gov/pubmed/29041949 http://dx.doi.org/10.1186/s13075-017-1431-9 |
work_keys_str_mv | AT tejerasegurabeatriz incretinsinpatientswithrheumatoidarthritis AT lopezmejiasraquel incretinsinpatientswithrheumatoidarthritis AT dominguezluismariajesus incretinsinpatientswithrheumatoidarthritis AT deveragonzalezantoniam incretinsinpatientswithrheumatoidarthritis AT gonzalezdelgadoalejandra incretinsinpatientswithrheumatoidarthritis AT ubillabegona incretinsinpatientswithrheumatoidarthritis AT olmosjosem incretinsinpatientswithrheumatoidarthritis AT hernandezjosel incretinsinpatientswithrheumatoidarthritis AT gonzalezgaymiguela incretinsinpatientswithrheumatoidarthritis AT ferrazamaroivan incretinsinpatientswithrheumatoidarthritis |